Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Capsovision Inc (CV)

Capsovision Inc (CV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CapsoVision Reports Second Quarter 2026 Financial Results GlobeNewswire - Thu Aug 13, 3:05PM CDT

SARATOGA, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
CapsoVision® Announces International Launch of AI Highlights GlobeNewswire - Mon Aug 3, 3:30PM CDT

SARATOGA, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026 GlobeNewswire - Thu Jul 30, 3:05PM CDT

SARATOGA, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
Visteon Announces Second Quarter 2026 Financial Results and $200 Million Accelerated Share Repurchase Program PR Newswire - Thu Jul 23, 5:55AM CDT

VAN BUREN TOWNSHIP, Mich. , July 23, 2026 /PRNewswire/ -- Visteon Corporation (NASDAQ: VC) today reported second quarter financial results. Highlights include:

CV : 6.66 (+3.10%)
VC : 107.49 (-0.67%)
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors GlobeNewswire - Thu Jul 2, 3:05PM CDT

SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
MarketBeat.com
CapsoVision Q1 Earnings Call Highlights MarketBeat - Thu May 14, 6:10PM CDT

CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal...

CV : 6.66 (+3.10%)
CapsoVision Reports First Quarter 2026 Financial Results GlobeNewswire - Thu May 14, 3:05PM CDT

SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 GlobeNewswire - Thu Apr 30, 3:05PM CDT

SARATOGA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results GlobeNewswire - Thu Mar 26, 3:05PM CDT

SARATOGA, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.66 (+3.10%)
CapsoVision Announces $14 Million Private Placement Financing GlobeNewswire - Fri Mar 20, 7:00AM CDT

SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (the “Company”) (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule...

CV : 6.66 (+3.10%)

Barchart Exclusives

Fortinet Stock Is Still a Buy After Hitting New All-Time Highs Barchart - 4 minutes ago
Fortinet (FTNT) demonstrates strong momentum, with a 98% gain over the past year. FTNT is projected to grow revenue 19.41% this year and 10.97% next year, with earnings expected to rise 25.02% and 8.95%, respectively. Analyst sentiment is broadly positive with price targets ranging from $102 to $220. Technical indicators... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.